« previous next »
Pages: [1]

Author Topic: (Abst.) Ocrelizumab depletes T-lymphocytes more than rituximab in MS  (Read 36 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9542
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Ocrelizumab depletes T-lymphocytes more than rituximab in MS
« on: February 10, 2021, 09:39:05 pm »
From PubMed (February 9, 2021)--"Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis":


https://pubmed.ncbi.nlm.nih.gov/33556652/
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
2 Replies
427 Views 		Last post December 26, 2016, 02:47:31 pm
by agate
0 Replies
108 Views 		Last post February 12, 2018, 04:07:56 pm
by agate
0 Replies
117 Views 		Last post August 04, 2018, 08:32:29 am
by agate
0 Replies
60 Views 		Last post January 18, 2020, 08:32:41 pm
by agate
0 Replies
7 Views 		Last post November 01, 2022, 09:38:58 pm
by agate